Genmab — December 2024
-
Helt enig
-
For mig er det lidt svært at tage Novod seriøst..... Jeg skal ikke kloge i hans agenda, men positiv er den i hvert fald ikke.... - Er det nu tredje gang i år at han er ude lufte hans tanker om at han ikke tror at JnJ vil opt.in.... Det er sgu tankevækkende...
-
Har skrevet en lille kommentar til Helges udsagn i investeringspodcasten om, at Epco ikke har samme potentiale som Dara. Det er med grov filen i beregningerne, men kom gerne med kommentarer, så kan vi gå i detaljer hvis nødvendigt. https://proinvestor.com/boards/123432
-
Acasunlimab / GEN1046 NSCL Safety trial has Primary Completion. https://clinicaltrials.gov/study/NCT05117242?tab=history&a=34&b=35&compareMode=sideBySide#version-content-panel
-
Jeg tror, at familier
-
'Biotech outflows yet again this week' https://x.com/BiotechAnalysst/status/1867585520483938610/photo/1 - 40 out of 50 weeks of outflows YTD
-
Jeg tror, at familien skal være glad for, at julegaverne er købt....
-
Årets ord: Fedtemøg.....tjaaa
-
Tak for dagens bidrag Pensionisten. Der er plads til alle
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind